Morphine Titration by Patient Self-controlled by a Mechanical Device Versus Administration by the Nurse for Patients With Severe Acute Pain in the Emergency Department
TACIDOU
Titration Morphinique autocontrôlée Par le Patient Par un Dispositif mécanique à Usage Unique Versus Administration Par l'infirmière Chez Les Patients Ayant Une Douleur aiguë sévère Aux Urgences.
1 other identifier
interventional
200
1 country
2
Brief Summary
Intense acute pain is a common reason for Emergency admittance and its management is one of the major public health goals. In the recommendations formalized experts, it is recommended to use a protocol titration with morphine bolus of 2 mg (for patients less than 60 kg) or 3 mg (for patients over 60 kg) repeated every 5 minutes with a target of the Visual Analog Scale less than or equal to 30. Despite these specific recommendations and a broad awareness of the teams, management of pain remains to be improved, the major difficulty of morphine titration at the emergency department being the availability of paramedical personnel to perform revaluations and reinjection. Thus, effective analgesia would be obtained in 50% of cases to 30 minutes. The investigators want to study the self-controlled morphine titration by the patient by a mechanical device for single use (efficacy/safety).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Jul 2014
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2014
CompletedFirst Posted
Study publicly available on registry
June 2, 2014
CompletedStudy Start
First participant enrolled
July 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2016
CompletedJune 30, 2016
June 1, 2016
1.6 years
May 22, 2014
June 29, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual Analog Scale <30
Evaluate the effectiveness of the analgesia of morphine titration self-controlled by the patient using a PCA device for single use ("PCA" group) opposing to an opioid titration carried out by the nurse (group 'Control')
30min
Secondary Outcomes (2)
Evaluate the effectiveness in the group Patient Controlled Analgesy
4h
Satisfaction
4h
Other Outcomes (1)
Assess the safety in the group Patient Controlled Analgesy
4h
Study Arms (2)
Patient Controlled Analgesy group
EXPERIMENTALTitration of morphine by Patient Controlled Analgesy. The opioid titration will be performed by the patient using PCA (Vygon Freedom 5) according to the principle of self with a refractory period of 5 minutes.
Control group
NO INTERVENTIONtitration will be perform in the usual manner in accordance with the recommendations : a nurse will assess pain using a visual analog scale in the control group to assess the need for a new bolus of morphine
Interventions
PCA is never used for titration but only for relay of titration. Self-controlled analgesia by PCA is our intervention.
Eligibility Criteria
You may qualify if:
- Admission to an emergency department
- Acute pain (Visual Analog Scale \> 60)
- Able to assess pain using the numerical scale
- Prescription of morphine titration
You may not qualify if:
- Physical or mental disorders limiting the understanding and / or use of a PCA
- History of allergy to morphine / hypersensitivity to any component
- Long-term treatment morphine
- History of Substance Abuse
- Severe respiratory insufficiency
- Severe hepatic impairment
- Head trauma
- Intracranial hypertension
- Uncontrolled epilepsy
- Pregnant or lactating
- Patient jailed
- Incapacitated adult under guardianship
- Incapable of giving informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
SCHOTTE Thibault
Angers, 49933, France
CHOUKROUN Jacques
Le Mans, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
ROY Pierre-Marie, MD-PhD
UH Angers
- PRINCIPAL INVESTIGATOR
SCHOTTE Thibault, Physician
UH Angers
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 22, 2014
First Posted
June 2, 2014
Study Start
July 1, 2014
Primary Completion
February 1, 2016
Study Completion
February 1, 2016
Last Updated
June 30, 2016
Record last verified: 2016-06